Dendreon U.S. trustee eliminates one member of creditor committee

By Kali Hays

New York, March 12 – Dendreon Corp. U.S. trustee Roberta A DeAngelis removed one member from the company’s official committee of unsecured creditors, according to a March 12 notice with the U.S. Bankruptcy Court for the District of Delaware.

Richard Feliciano of the American Red Cross of Washington, D.C., was released from the committee.

Remaining members of the committee are Jeffery W. Jacobs of Document Technologies, LLC of Atlanta; Thomas A. McKean of Piedmont – Bridgewater NJ, LLC of John Creek, Ga.; and Tim Thelen of GlaxoSmithKlein of Research Triangle Park, N.C.

Dendreon, a Seattle-based biotechnology company that focuses on novel therapeutics to enhance cancer treatment options, filed for bankruptcy on Nov. 10. The Chapter 11 case number is 14-12515.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.